# TORL Biotherapeutics LLC — Form D

TORL Biotherapeutics LLC of Culver City, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-17. The offering totals $158.3M, of which $158.3M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2024-04-17
- Form: D
- Accession: 0001797180-24-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $158.3M
- Amount sold: $158.3M
- Investors: 52
- Date of first sale: 2024-04-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-510814

## Issuer

- Name: TORL Biotherapeutics LLC
- CIK: 0001797180
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Address: 6100 Bristol Parkway, Culver City, CA, 90230
- Phone: (424) 652-9370

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Mark Alles | Director | Culver City, CA |
| Mark Attanasio | Director | Los Angeles, CA |
| David Licata | Director | Culver City, CA |
| Neil O'Brien | Director | Culver City, CA |
| Lynn Seely | Director | Culver City, CA |
| Amit Sinha | Director | Culver City, CA |
| Dennis Slamon | Director | Culver City, CA |
| Mark Alles | Executive Officer | Culver City, CA |
| David Licata | Executive Officer | Culver City, CA |

## More

- [CIK 1797180 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1797180&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001797180-24-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.